Merit Medical Systems Inc (MMSI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $5.17B
Last updated: Nov 17, 2026 at 4:26 PM ET
Merit Medical Systems Inc (MMSI) Statistics
Merit Medical Systems (MMSI) has a market cap of $5.17B and an enterprise value of $5.41B. Its trailing P/E of 20.7x is below its 10-year median of 27.6x.
Total Valuation
Enterprise value is 4.52% above the market cap, as debt exceeds cash.
| Market Cap | $5.17B |
|---|---|
| Enterprise Value | $5.41B |
| Latest price (Nov 17, 2026) | $84.49 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.1x and 2.9x. Its year-end P/E ranged from 21.2x to 33.6x from 2016 to 2025.
| P/E Ratio | 20.7x |
|---|---|
| Forward P/E | 19.0x |
| P/S Ratio | 3.1x |
| Forward P/S | 3.2x |
| P/B Ratio | 2.9x |
| P/TBV Ratio | 8.2x |
| P/FCF Ratio | 24.8x |
| P/OCF Ratio | 18.9x |
| PEG Ratio | 2.6 |
Enterprise Valuation
Counting debt and cash, the company is valued at 14.3x EBITDA and 26.0x free cash flow.
| EV / Earnings | 33.8x |
|---|---|
| EV / Sales | 3.4x |
| EV / EBITDA | 14.3x |
| EV / EBIT | 23.7x |
| EV / FCF | 26.0x |
Price Statistics
The stock is down 0.71% over 52 weeks and trades 3.88% below its 50-day average.
| Beta (1Y) | 0.51 |
|---|---|
| 52-Week Change | -0.71% |
| 1-Month Change | -6.08% |
| 3-Month Change | -8.14% |
| 6-Month Change | +32.49% |
| 5-Year Change | +28.22% |
| 10-Year Change | +292.89% |
| Total Return (1Y) | -0.71% |
| Total Return (3Y CAGR) | +5.79% |
| Total Return (5Y CAGR) | +4.41% |
| Return vs SPY (1Y) | -11.18% |
| Max Drawdown (1Y) | -35.28% |
| Max Drawdown (3Y) | -45.32% |
| Sharpe Ratio (1Y) | 0.01 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $87.90 |
| 200-Day Average | $77.26 |
| 52-Week Range | $59.74 to $94.85 |
| RSI (14 Days) | 40.2 |
| Average Volume (20 Days) | 756.78K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.52x current liabilities, and total debt is 0.42x shareholder equity.
| Current Ratio | 4.52x |
|---|---|
| Quick Ratio | 3.05x |
| Debt / Equity | 0.42x |
| Debt / EBITDA | 1.99x |
| Debt / FCF | 3.62x |
| Interest Coverage | 7.06x |
Returns and Efficiency
Return on invested capital is 6.96% over the last 12 months, against a 5-year average of 5.32%.
| Return on Equity (ROE) | 9.18% |
|---|---|
| Return on Assets (ROA) | 5.47% |
| Return on Invested Capital (ROIC) | 6.96% |
| Return on Capital Employed (ROCE) | 8.59% |
| ROE (5Y Average) | 7.17% |
| ROA (5Y Average) | 4.25% |
| ROIC (5Y Average) | 5.32% |
| Asset Turnover | 0.58x |
| Inventory Turnover | 2.13x |
| Receivables Turnover | 7.22x |
| Cash Conversion Cycle | 191 days |
Taxes
Income tax took 24.37% of pretax income over the last 12 months.
| Income Tax (TTM) | $51.59M |
|---|---|
| Effective Tax Rate | 24.37% |
Scores
MMSI has an Altman Z-Score of 4.21, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.21 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.61B over the last 12 months is up 9.06% from the 12 months before.
| Revenue | $1.61B |
|---|---|
| Revenue Growth (YoY) | +9.06% |
| Gross Profit | $795.95M |
| Operating Income | $217.52M |
| Pretax Income | $211.71M |
| Net Income | $160.12M |
| EBITDA | $370.40M |
| EBIT | $228.36M |
| Reported EPS (TTM) | $4.08 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 59.59% of the $2.92B in total assets.
| Cash and Equivalents | $503.55M |
|---|---|
| Total Debt | $737.40M |
| Net Debt | $233.85M |
| Net Debt Per Share | $3.91 |
| Working Capital | $933.73M |
| Shareholder Equity | $1.74B |
| Book Value Per Share | $29.17 |
| Tangible Book Value | $616.21M |
| Tangible Book Per Share | $10.30 |
| Total Assets | $2.92B |
| Total Liabilities | $1.18B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $70.15M of capital spending, operating cash flow left $203.59M of free cash flow.
| Operating Cash Flow | $273.74M |
|---|---|
| Capital Expenditures | $70.15M |
| Free Cash Flow | $203.59M |
| FCF Per Share | $3.41 |
| Depreciation and Amortization | $142.03M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 13.50%, against a 5-year average of 9.36%.
| Gross Margin | 49.41% |
|---|---|
| Operating Margin | 13.50% |
| Pretax Margin | 13.14% |
| Net Margin | 9.94% |
| EBITDA Margin | 22.99% |
| EBIT Margin | 14.18% |
| FCF Margin | 12.64% |
| Gross Margin (5Y Average) | 46.56% |
| Operating Margin (5Y Average) | 9.36% |
| Net Margin (5Y Average) | 7.17% |
Growth
Revenue grew 9.61% a year over 3 years, and EPS 12.50% a year.
| Revenue Growth (3Y CAGR) | +9.61% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.48% |
| EPS Growth (3Y CAGR) | +12.50% |
| EPS Growth (5Y CAGR) | +18.34% |
| FCF Growth (3Y CAGR) | +46.02% |
| FCF Growth (5Y CAGR) | +12.57% |
| Operating Income Growth (3Y CAGR) | +28.25% |
| Book Value Per Share Growth (2Y CAGR) | +13.23% |
| Tangible Book Per Share Growth (2Y CAGR) | +3.11% |
Dividends and Yields
MMSI does not pay a dividend. Its free cash flow yield is 4.03%.
| Earnings Yield | 4.83% |
|---|---|
| FCF Yield | 4.03% |
| Buyback Yield | -0.44% |
| Shareholder Yield | -0.44% |
Peer Position
Against 10 similar companies, MMSI has the 6th highest P/E.
P/E RatioPeer median 21.1x
P/S RatioPeer median 2.9x
ROICPeer median 6.74%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.20%
| P/E Ratio | 20.7x vs 21.1x median |
|---|---|
| P/S Ratio | 3.1x vs 2.9x median |
| ROIC | 6.96% vs 6.74% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.06% vs +6.20% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.14% and EPS growth at 10.42% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.14% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.42% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MMSI
What is MMSI's market cap?
Merit Medical Systems has a market cap of $5.17B. Its enterprise value, which adds debt and subtracts cash, is $5.41B.
What is MMSI's P/E ratio?
Merit Medical Systems has a trailing P/E ratio of 20.7x and a forward P/E of 19.0x.
How many shares of MMSI are outstanding?
Merit Medical Systems has 59.81M shares outstanding. The count is up 0.95% from a year earlier.
Does MMSI pay a dividend?
No. Merit Medical Systems does not pay a dividend.
How much debt does MMSI have?
Merit Medical Systems has $737.40M of total debt and $503.55M of cash and equivalents, a net debt position of $233.85M.
MMSI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts